Table 2 Prevalence OR^# of musculoskeletal complaints (MSCs) related to DM and non-fasting glucose levels

DM

No

62,629

46.2

1.0 (reference)

5.0

1.0 (reference)

41.3

1.0 (reference)

Yes

1,940

56.9

1.2 (1.1–1.3)

5.9

1.3 (1.1–1.6)

51.0

1.1 (1.0–1.3)

No, but glucose ≥ 11.1

216

45.4

0.7 (0.5–0.9)

5.1

0.8 (0.4–1.5)

40.3

0.7 (0.5–0.9)

DM

No

62,629

42.2

1.0 (reference)

5.0

1.0 (reference)

41.3

1.0 (reference)

Type 1

122

45.9

1.0 (0.7–1.5)

3.3

0.7 (0.2–1.9)

42.6

1.1 (0.7–1.6)

Type 2

1,120

57.7

1.1 (1.0–1.3)

6.1

1.3 (1.0–1.7)

51.6

1.1 (1.0–1.3)

LADA

127

56.7

1.1 (0.8–1.6)

5.5

1.2 (0.5–2.6)

51.2

1.2 (0.8–1.7)

Unclassified

571

57.8

1.2 (1.0–1.5)

6.3

1.6 (1.1–2.3)

51.5

1.2 (1.0–1.4)

No, but glucose ≥ 11.1

216

45.4

0.7 (0.5–0.9)

5.1

0.8 (0.4–1.5)

40.3

0.7 (0.5–0.9)

Serum glucose

≤ 4.7 mmol/l

16,198

43.2

1.0 (reference)

4.8

1.0 (reference)

38.3

1.0 (reference)

4.8–5.2 mmol/l

19,151

46.7

1.0 (0.9–1.0)

5.2

1.0 (0.9–1.1)

41.4

1.0 (0.9–1.0)

5.3–5.8 mmol/l

14,737

47.9

0.9 (0.9–1.0)

5.1

0.9 (0.8–1.0)

42.8

0.9 (0.9–1.0)

≥ 5.9 mmol/l

14,316

49.1

0.9 (0.8–0.9)

5.0

0.8 (0.7–0.9)

44.2

0.9 (0.8–0.9)

Missing

383

36.6

0.6 (0.5–0.8)

0.8

0.1 (0.0–0.4)

35.8

0.6 (0.5–0.8)

P-trend value^$

< 0.001

< 0.001

< 0.001

P trend value^$ (β)

< 0.001 (-,022)

0.045 (-,026)

< 0.001 (-,021)